Merrill M. Kraines advises life sciences and technology clients in corporate, securities, and mergers and acquisition transactions. He has in-depth experience representing biotechnology, therapeutic, diagnostic and medical device companies. Merrill also represents emerging companies in various business and finance transactions in many industries, including: software, Internet, healthcare, IT, alternative energy, financial services, IT consulting, educational publishing, entertainment, office products, advertising, telecommunications, paper and more. Merrill handles numerous IPO’s and secondary offerings, including fully marketed underwritten offerings, registered direct and confidentially marketed offerings, uplistings, off-the-shelf takedowns, private placements, PIPE financings, and cross-over and venture capital financings.

Show More


Health Sciences Securities Offerings

  • Represented Spine BioPharma, Inc. in a $13 million Series B Preferred Stock investment by Viscogliosi Bros., LLC, Cercano Management, Pacira Biosciences and others
  • Represented Applied DNA Sciences, Inc. in a $4.2 million registered direct offering of common stock and pre-funded warrants and a concurrent private placement of warrants to an institutional investor placed by Roth Capital Partners*
  • Represented PharmaCyte Biotech, Inc. in a $70 million registered direct offering of common stock and pre-funded warrants to institutional investors placed by HC Wainwright*

Show More


  • Who’s Who in American Law


  • NYU Hospital for Joint Diseases
    • Rusk Rehabilitation Institute
    • Center for Musculoskeletal Care
    • Musculoskeletal Advisory Board of Trustees

Show More


Columbia Law School, JD, 1979
Dartmouth College, BA, magna cum laude, 1976

New York